Evidence map›Paper›PMID 34934636›Full record

ReviewToxicology reports2022

Impact of COVID-19 acute respiratory disease on the risk factors attributed to cancer patients.

Elena Lak, Mohammad Javad Mohammadi, Homayon Yousefi

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Toxicology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Elena LakAssistant Professor of Gastroenterology and Hepatology, Department of Internal Medicine, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Mohammad Javad MohammadiDepartment of Environmental Health Engineering, School of Health AND Air Pollution and Respiratory Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Homayon YousefiAssistant Professor of Pediatric Hematology and Oncology, Department of Internal Medicine, School of Medicine AND Thalassemia & Hemoglobinopathy Research center, Health research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Ahvaz Jundishapur University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Communicable diseases (CDs) based on Health organization reported are one of the most threat for human health. SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) is the main pandemic that nowadays it threatens the health of people around the world, especially cancer patients. The purpose of this study was to investigate the effects of COVID-19 acute respiratory disease (COVID-19 ARD) on risk factors related to health of cancer patients. A review study of was conducted to base on results of various studies published. Nine hundred and eighty articles were retrieved based on various databases: Science Direct, Taylor & Francis, Google Scholar, Elsevier, PubMed and BMJ. In this study, were used the results of research on COVID-19 and its effects on risk factors attributed to cancer patients. The literature signs a notable undesirable affect from COVID-19 on risk factors attributed to health of cancer patients. Result showed that transfer SARS-CoV-2 viruses can endanger health of cancer patients due to interruption of the disease treatment process and increase number of deaths between in this patents. The survey requires the need to act creating healthy conditions to continue the treatment process and vaccination coverage among these patients in order to decrease the transmission of COVID-19 acute respiratory disease and increase the success rate of cancer treatment.

Indexed as

AACR, American Association of Cancer ResearchAcute respiratory diseaseASCO, American Society of Clinical OncologyCancerCCC-19, COVID-19 and Cancer ConsortiumCDs, Communicable diseasesCommunicable diseasesCOVID-19COVID-19 ARD, acute respiratory diseaseCOVID-19, coronavirus disease 2019ESCA, Esophageal carcinomaESMO, European Society for Medical OncologyHealthICU, Intensive Care UnitKICH, Kidney ChromophobeKIRP, Kidney renal papillary cell carcinomaLUAD, Lung adenocarcinomaPCR, Real-time Polymerase Chain ReactionPRAD, Prostate adenocarcinomaRisk factorsSARS-CoV-2, severe acute respiratory syndrome coronavirus 2UCEC, Uterine Corpus Endometrial CarcinomaWHO, World Health Organization

Identifiers

PMID34934636
PMCPMC8674635
OpenAlexW4200347455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.